SNHG12 stimulates EMT in lung cancer by ceRNA targeting of miR-218 (132), and mediates doxorubicin resistance via miR-320a repression and MCL1 (MCL1 apoptosis regulator, BCL2 family member) up-regulation in osteosarcoma (133). This evidence concerns the gene SNHG12 and lung carcinoma.